InvestorsHub Logo
Followers 30
Posts 4325
Boards Moderated 0
Alias Born 03/20/2011

Re: None

Friday, 05/12/2023 5:08:32 PM

Friday, May 12, 2023 5:08:32 PM

Post# of 264
Novartis Collaboration:

https://ih.advfn.com/stock-market/NASDAQ/tscan-therapeutics-TCRX/stock-news/91014982/quarterly-report-10-q

"The Company will continue to assess the probability of milestone
payments throughout the180-day right of first negotiation period"
.

What insights are available into what TCRX might have discovered during the Novartis collaboration period, and to whom would these TCR targets be of concern/value to? And to what monetary value are such TCR discoveries worth/to Novartis/others.

Deadline for the 180-day right of first negotiation period, in and around September 28 by my count.

Given the Amgen news came out, out of nowhere, so to, could news on licensing/Novartis come out anytime to Sept.28/23.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News